TransMedics Group, Inc. ( TMDX) - Key Metrics
TMDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.49 | $0.42 | $0.50 | $0.30 |
| 2026Q1 | $5.06 | $0.21 | $0.71 | -$0.35 |
| 2025Q4 | $4.70 | $3.08 | $1.01 | $0.56 |
| 2025Q3 | $4.22 | $0.71 | $2.04 | $1.82 |
| 2025Q2 | $4.64 | $1.03 | $2.70 | $2.43 |
TMDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 39.54 |
| 2026Q1 | 0% | 118.35 |
| 2025Q4 | 0% | 9.87 |
| 2025Q3 | 0% | 39.51 |
| 2025Q2 | 0% | 32.53 |
TMDX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.44% | 0% |
| 2026Q1 | -0.35% | 0% |
| 2025Q4 | 0.46% | 0% |
| 2025Q3 | 1.62% | 0% |
| 2025Q2 | 1.82% | 0% |
TMDX
Price: $88.58
52 week price:
Earnings Per Share: 4.07 USD
P/E Ratio: 21.72
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 513900
Market Capitalization: 3.1 billion